TruBridge (NASDAQ:TBRG) Given Equal Weight Rating at Stephens

Stephens reissued their equal weight rating on shares of TruBridge (NASDAQ:TBRG) in a research report sent to investors on Thursday,Benzinga reports. They currently have a $28.00 target price on the stock.

Separately, Cantor Fitzgerald raised their price target on TruBridge from $20.00 to $29.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 11th.

TruBridge Stock Down 5.1 %

TBRG opened at $24.54 on Thursday. The company has a market capitalization of $366.85 million, a PE ratio of -6.00, a P/E/G ratio of 5.38 and a beta of 0.64. TruBridge has a one year low of $7.61 and a one year high of $32.00. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80. The stock’s fifty day moving average is $27.47 and its 200-day moving average is $20.71.

Insider Activity at TruBridge

In other news, major shareholder Pinetree Capital Ltd. purchased 74,981 shares of TruBridge stock in a transaction on Thursday, February 13th. The stock was purchased at an average price of $27.61 per share, with a total value of $2,070,225.41. Following the transaction, the insider now directly owns 693,981 shares in the company, valued at $19,160,815.41. The trade was a 12.11 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Christopher L. Fowler sold 5,100 shares of the firm’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $27.02, for a total transaction of $137,802.00. Following the completion of the transaction, the chief executive officer now directly owns 142,939 shares of the company’s stock, valued at approximately $3,862,211.78. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have bought 116,728 shares of company stock worth $3,239,879 in the last ninety days. Company insiders own 10.70% of the company’s stock.

Institutional Trading of TruBridge

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Federated Hermes Inc. lifted its stake in TruBridge by 3.1% in the 4th quarter. Federated Hermes Inc. now owns 468,758 shares of the company’s stock valued at $9,244,000 after purchasing an additional 14,120 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in TruBridge by 12.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 348,941 shares of the company’s stock valued at $6,881,000 after buying an additional 38,902 shares during the period. Truffle Hound Capital LLC acquired a new stake in shares of TruBridge in the fourth quarter valued at approximately $5,916,000. D. E. Shaw & Co. Inc. boosted its stake in shares of TruBridge by 8.4% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 217,539 shares of the company’s stock worth $4,290,000 after acquiring an additional 16,821 shares during the period. Finally, Susquehanna International Group LLP increased its holdings in shares of TruBridge by 343.6% during the 4th quarter. Susquehanna International Group LLP now owns 209,871 shares of the company’s stock worth $4,139,000 after acquiring an additional 162,560 shares during the last quarter. 88.64% of the stock is owned by institutional investors.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.